Leserbrief
IgM antiphospholipid antibody testing has minimal clinical utility as a routine diagnostic test
Pathology · 2026-10
DOI: 10.1016/j.pathol.2026.09.003 ↗Kurz gefasst
Leserbrief in der Zeitschrift Pathology, 2026-10. Verfasst von Subin Wui und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Randwick, NSW, Australia. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Randwick, NSW, Australia.
- South Eastern Sydney Immunology Laboratory, Randwick, NSW, Australia.
- School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Randwick, NSW, Australia; South Eastern Sydney Immunology Laboratory, Randwick, NSW, Australia; Department of Immunology, Princ…
Zitieren
APA
Wui, S., Chalmers, T., Wei, X., & Yun, J. (2026). IgM antiphospholipid antibody testing has minimal clinical utility as a routine diagnostic test. Pathology. https://doi.org/10.1016/j.pathol.2026.09.003
Vancouver
Wui S, Chalmers T, Wei X, Yun J. IgM antiphospholipid antibody testing has minimal clinical utility as a routine diagnostic test. Pathology. 2026. doi:10.1016/j.pathol.2026.09.003
BibTeX
@article{Wui2026,
author = {Wui, Subin and Chalmers, Thomas and Wei, Xiumei and Yun, James},
title = {IgM antiphospholipid antibody testing has minimal clinical utility as a routine diagnostic test},
journal = {Pathology},
year = {2026},
doi = {10.1016/j.pathol.2026.09.003}
}
EUVIMED